Relapsed/Refractory Solid Tumors/Hematological Malignancies
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Solid Tumors/Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment. (NCT02679131) | Acrotech Biopharma Inc. | 2016-03-01 |
Track Relapsed/Refractory Solid Tumors/Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.